G1m1 Predominance of Intrathecal Virus-Specific Antibodies in Multiple Sclerosis

Annals of Clinical and Translational Neurology - United States
doi 10.1002/acn3.642
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Virus Specific Antibodies in Multiple Sclerosis.

BMJ
1972English

Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients With Multiple Sclerosis

PLoS ONE
Multidisciplinary
2011English

Intrathecal Interferon for Multiple Sclerosis

Science
MultidisciplinaryPhilosophy of ScienceHistory
1982English

Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis

JAMA - Journal of the American Medical Association
Medicine
2001English

Anti-Dna Antibodies Are a Major Component of the Intrathecal B Cell Response in Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Intrathecal Effects of Daclizumab Treatment of Multiple Sclerosis

Neurology
Neurology
2011English

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis

Frontiers in Neurology
Neurology
2014English

Rickettsial and Viral Antibodies in Multiple Sclerosis

BMJ
1962English

Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy